V
V. Ravichandiran
Researcher at Vels University
Publications - 8
Citations - 23
V. Ravichandiran is an academic researcher from Vels University. The author has contributed to research in topics: Medicine & Vitamin D and neurology. The author has an hindex of 2, co-authored 8 publications receiving 10 citations.
Papers
More filters
Journal ArticleDOI
Knowledge, attitude and practices towards visceral leishmaniasis among HIV patients: A cross-sectional study from Bihar, India.
J S Devipriya,Ashok Kumar Gupta,Rajendra Babu Veeri,Pavan Garapati,Rishikesh Kumar,Sameer Dhingra,Krishna Murti,V. Ravichandiran,Krishna Pandey +8 more
TL;DR: In this article, a questionnaire based cross-sectional study was performed among 120 HIV patients aged ≥18 years, to evaluate their knowledge, attitude, and practices regarding visceral leishmaniasis.
Formulation and Physico-Chemical Evaluation of Ethylcellulose Microspheres Containing Etodolac
TL;DR: In this paper, the effect of increase in polymer concentration in various parameters like particle size, drug content, percentage yield, entrapment efficiency and in vitro release profile were studied.
Journal Article
Preparation and characterization of gemcitabine loaded mpeg-pcl polymeric nanoparticles for improved transportation across blood brain barrier
TL;DR: It can be concluded that GCB loaded MPEG-PCL nanoformulation can serve as a potential drug delivery tool for the treatment of brain tumours.
Journal ArticleDOI
Rays of immunity: Role of sunshine Vitamin in management of COVID-19 infection and associated comorbidities
V. Udaya kumar,Garapati Pavan,Krishna Murti,Rajesh Kumar,Sameer Dhingra,Mainul Haque,V. Ravichandiran +6 more
TL;DR: In this paper, the authors reviewed the current standpoint scenario and future prevalence of vitamin D supplementation in the management of covid-19 patients and suggested that along with regulation of cell growth, neuroprotective and mood-stabilizing effects, it regulates the immune response also modulates cytokine Interleukin-6 (IL-6) by inducing progesterone-induced blocking factor (PIBF), given the IL-6 levels are considerably high in COVID-19 patient which increases the further complications.
Journal ArticleDOI
An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia.
Siddhartha Dutta,Sayeeda Rahman,Rahnuma Ahmad,Tarun Kumar,Gitashree Dutta,Sudeshna Banerjee,Abdullahi Rabiu Abubakar,Adekunle Babajide Rowaiye,Sameer Dhingra,V. Ravichandiran,Santosh Kumar,Paras Sharma,Mainul Haque,Jaykaran Charan +13 more
TL;DR: In this article, the role of cholesterol in the pathogenesis of dementia and statin as a therapeutic intervention in dementia is discussed, and evidence in support of as well as against statin therapy in dementia, recent updates of statin pharmacology, and demerits of use of pharmacotherapy.